About us >

Biomarker landscape

The cardiovascular biomarker landscape is rapidly changing from mono marker assays to multimarker panels. The discovery of microRNAs as a new class of circulating biomarkers and the introduction of game-changing multi analyte technology platforms allow full cardiovascular risk profiling by simultaneously measuring a biomarker panel composed of miRNAs and proteins.
Read more

Next generation diagnostics

miRNAs are new players in the field of blood based biomarkers and hold great promise as clinically useful markers for cardiovascular diseases. Including miRNAs in multi-marker panels adds significant benefits as they reflect many more parts of the complex underlying cardiovascular pathophysiology. 


ACS Biomarkers key goal is to develop the next generation of IVD assays capitalising on the strength of established protein markers and adding value of recently discovered miRNAs.
Read more